Pulmonary effects of acebutolol, a "cardioselective" beta adrenergic blocking agent.

Author: CostelloR B, DiBiancoR, DickieK J, FletcherR D, GottdieneJ S, KatzR J, LadduA R, SinghS

Paper Details 
Original Abstract of the Article :
The effect of chronic oral therapy with acebutolol, a cardioselective beta adrenergic blocking agent, was evaluated on resting pulmonary functions in a group of patients who were free of overt obstructive airways disease and who had chronic stable angina pectoris. The study design involved a 20-week...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/6120142

データ提供:米国国立医学図書館(NLM)

The Effects of Acebutolol on Pulmonary Function

This research delves into the fascinating world of cardiology, specifically the effects of acebutolol, a "cardioselective" beta adrenergic blocking agent, on pulmonary function. Think of it as a detective story where we're trying to understand how this medication affects the delicate balance of your lungs! This study employed a rigorous, double-blind, randomized cross-over trial, akin to a carefully orchestrated mystery, to explore the impact of acebutolol on patients with stable angina pectoris. The researchers, like meticulous investigators, used various techniques such as spirometry, flow volume loops, and arterial blood gas analyses to gather clues. Their findings revealed a surprising twist: acebutolol did not have any adverse effects on resting pulmonary function when used in clinically effective dosages. It's as if acebutolol, despite its role in treating heart conditions, left the lungs unscathed.

Acebutolol's Non-Impact on Pulmonary Function

This research suggests that acebutolol, while potentially beneficial for the heart, seems to have no negative impact on the lungs. This finding holds significance for patients with heart conditions who may also have concerns about their respiratory health. It's as if acebutolol is a double agent working to benefit the heart without betraying the lungs.

A Lung-Friendly Approach to Heart Health

This research provides valuable information for individuals taking acebutolol for heart conditions, assuring them that it is likely to be a lung-friendly option. Imagine a desert oasis where the heart finds solace and the lungs remain untouched, a harmonious balance achieved through this medication.

Dr.Camel's Conclusion

This study reveals that acebutolol is a double agent in the best way possible, helping the heart without harming the lungs. It's a reassuring discovery for patients seeking effective treatment for their heart conditions while maintaining respiratory well-being.

Date :
  1. Date Completed 1982-04-22
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

6120142

DOI: Digital Object Identifier

6120142

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.